CVR number 26513073
Industry 86.1000 Hospital activities

AK Nygart A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.9% 1.2% 2.3% 1.0% 1.0%  
Credit score (0-100)  71 82 64 84 86  
Credit rating  A A BBB A A  
Credit limit (kDKK)  19.6 1,864.9 0.9 3,381.0 3,714.3  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  53,989 41,673 36,596 44,792 45,964  
EBITDA  19,699 9,206 5,170 8,627 8,704  
EBIT  18,464 8,084 3,608 7,041 6,510  
Pre-tax profit (PTP)  19,047.0 9,110.8 5,539.1 10,226.4 9,923.7  
Net earnings  14,855.4 7,163.3 4,335.9 7,988.7 7,740.6  
Pre-tax profit without non-rec. items  19,047 9,111 5,539 10,226 9,924  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  2,589 2,383 4,610 4,059 10,630  
Shareholders equity total  35,261 42,424 46,760 54,749 62,490  
Interest-bearing liabilities  3,327 7,412 4,255 3,848 4,320  
Balance sheet total (assets)  66,954 69,154 70,669 81,439 87,818  
Net Debt  -4,650 -6,222 869 -2,713 -290  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  53,989 41,673 36,596 44,792 45,964  
Gross profit growth  8.6% -22.8% -12.2% 22.4% 2.6%  
Employees  34 34 31 33 31  
Employee growth %  3.0% 0.0% -8.8% 6.5% -6.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  66,954 69,154 70,669 81,439 87,818  
Balance sheet change%  37.8% 3.3% 2.2% 15.2% 7.8%  
Added value  19,699.0 9,206.3 5,170.0 8,603.7 8,703.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,745 -621 491 -1,592 4,072  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  34.2% 19.4% 9.9% 15.7% 14.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  33.4% 13.6% 8.2% 13.9% 12.1%  
ROI %  56.0% 20.7% 9.5% 16.0% 15.7%  
ROE %  53.4% 18.4% 9.7% 15.7% 13.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  61.5% 69.6% 105.6% 77.1% 77.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -23.6% -67.6% 16.8% -31.4% -3.3%  
Gearing %  9.4% 17.5% 9.1% 7.0% 6.9%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 3.2% 3.2% 7.6% 8.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.0 3.5 -9.2 7.3 6.7  
Current Ratio  2.1 2.5 33.9 3.7 4.0  
Cash and cash equivalent  7,976.8 13,633.5 3,385.8 6,561.5 4,609.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  32,700.2 38,459.9 62,256.9 54,556.1 55,792.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  579 271 167 261 281  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  579 271 167 261 281  
EBIT / employee  543 238 116 213 210  
Net earnings / employee  437 211 140 242 250